VisionGate receives $3 million in government grants

Phoenix, AZ, June 18, 2010 – VisionGate has been officially awarded a three-year, $2.62 million grant from NIH as part of an initiative called Biomedical Research, Development, and Growth to Spur the Acceleration of New Technologies (BRDG-SPAN) Program. The program is designed to provide funding for accelerating the market introduction of breakthrough technologies that “…will improve human health, help advance the mission of NIH and its Institutes and Centers (ICs), and create significant value and economic stimulus.” The peer-reviewed selection process for this program has been highly competitive: nationwide, only ten companies were elected to participate. The grant will be used to complete the development of VisionGate’s high-speed/high-throughput Cell-CT, a 3D-imaging platform with diagnostic applications in lung cancer and other important diseases.

Additionally, VisionGate has been awarded two grants through NIH’s Small Business Innovation Research (SBIR) program. Phase I of each grant is supported with approximately $200k, while substantially larger funds will be available when the projects enter Phase II.

Principal Investigator of the three grants is Thomas Neumann, MD, Vice President for Medical Sciences at VisionGate.

This website may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and made in reliance on the "safe harbor" provisions of said act. Forward-looking statements are based on estimates, projections, beliefs and assumptions of VisionGate® management at the time of such statements and are not guarantees of future performance. Forward-looking statements involve risks and uncertainties in predicting future results and conditions. Actual results could differ materially from those projected in these forward-looking statements due to a variety of factors, including, without limitation, the acceptance by customers of our products, our ability to develop new products cost-effectively, our ability to raise capital in the future, the development by competitors of products using improved or alternative technology, the retention of key employees and general economic conditions. Forward-looking statements are subject to change without notice.

Contact Us

If you are interested in learning more about VisionGate and would like to speak with someone, please complete this short inquiry form and a representative will contact you as soon as possible.

Copyright 2020 - VisionGate, Inc.